Author name: Frontiercell

Concept of the CATL formation-screening patent US12540983B2: a 2-D Gaussian of two features with a density-threshold boundary
Patent Analysis

[Patent Analysis] Screening Out Defective Cells From the First Charging Curve — The Boundary of the Formation-Data Method Claimed in CATL US12540983B2

CATL’s US12540983B2 claims a method that feeds the values at which dQ/dV, dynamic internal resistance or dV/dQ first reach two process variations in the first formation stage into a two-dimensional Gaussian model to screen out cells with electrolyte or moisture anomalies. We set out the claims and family, and why switching to Mahalanobis distance leaves the boundary unchanged.

Timeline of the CATL Debrecen battery plant in Hungary, from the 2022 announcement to cell trial production in September 2026
News & Trends

The Equipment Arrived in Spring, the Cells in Autumn — What CATL’s Debrecen Trial Production Shows About a European Plant’s Critical Path

CATL began cell trial production at its plant in Debrecen, Hungary, on September 22, 2026. Equipment installation ended in the spring, but trial production opened in the autumn after permitting. We look at what trial production validates and how process know-how and patents are protected and enforced in Hungary, which sits outside the UPC.

Closed-loop flow of the Fluence ESS capacity-management patent US12632024B2: node, storage, aggregation, estimation, corrective action
Patent Analysis

[Patent Analysis] When an Augmentation Decision Becomes a Claim — The Boundary of ESS Capacity Management in Fluence US12632024B2

Fluence’s US12632024B2 claims, as one closed loop, estimating ESS capacity from field data and taking a corrective action that adjusts temperature, configuration, number of components or material according to the result. We follow its rainflow partial-cycle dependent claim and three forms of independent claim to read the boundary of the rights and the room to design around them.

Scroll to Top